No Data
Senores Pharmaceuticals Increases Stake in Havix Group
＜Individual Stock Trends＞ Mariichi Pipe, Elan, Habix, Omron, Innotech = 12 days before the market.
Maruichi Pipe <5463.T> - Continues to sell part of its investment securities and upwardly revises the Financial Estimates for consolidated net profit for the fiscal year ending March 2025. Elan <6099.T> - Expects significant profit growth for the fiscal year ending December 2025 and plans to increase the year-end total Dividends estimate to 15 yen (previous period's result was 13 yen). Habix <3895.T> - Raises Financial Estimates for consolidated profit for the fiscal year ending March 2025. Omron <6645.T> - Consolidated financial results (in accordance with USA accounting standards) for the cumulative third quarter of the fiscal year ending March 2025 (April-December 2024) show net.
SoftBank's operating profit for Q3 increased by 12.3% to 821.8 billion yen.
The results for the third quarter of the fiscal year ending March 2025, announced by SoftBank <9434>, showed a revenue of 4 trillion 811.4 billion 63 million yen, a 6.6% increase compared to the same period last year, and an operating profit of 821.8 billion 61 million yen, a 12.3% increase year-on-year. PayPay's performance improved. The core mobile business also showed steady recovery from the impact of mobile price reductions. 【Positive assessment】 <6645> Omron quarter | <4284> Solxyz full year <7189> Nishi Nippon FH quarter | <7370> Enjin revision
Havix Corp 9-Mos Net Y499.00M Vs Net Y497.00M
Havix Corp Sees FY Net Y520.00M
Havix: Notice regarding revisions to the full-year consolidated earnings forecast for the fiscal year ending March 31, 2025